Sotalol for atrial tachycardias after surgery for congenital heart disease

PACE - Pacing and Clinical Electrophysiology

Volumn 20, Issue 8 II, 1997, Pages 2125-2129

  Beaufort Krol, Gertie C M ^a   Bink Boelkens, Margreet T H E ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Atrial flutter; Atrial tachycardia; Congenital heart disease; Sotalol

Indexed keywords

DIGOXIN; SOTALOL;

ADOLESCENT; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CARDIOVERSION; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONGENITAL HEART DISEASE; FATIGUE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; ORAL DRUG ADMINISTRATION; SICK SINUS SYNDROME; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; CHILD; DISEASE-FREE SURVIVAL; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FATIGUE; FOLLOW-UP STUDIES; HEART ATRIA; HEART DEFECTS, CONGENITAL; HEART RATE; HUMANS; PACEMAKER, ARTIFICIAL; POSTOPERATIVE COMPLICATIONS; RECURRENCE; SICK SINUS SYNDROME; SOTALOL; SURVIVAL RATE; TACHYCARDIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030785667     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1997.tb03642.x     Document Type: Article

References (39)

1. Balaji S, Gewillig M, Bull C, et al. Arrhythmias after the Fontan procedure. Circulation 1991; 84:III-162-III-167.
2. Bink-Boelkens MThE, Velvis H, Homan van der Heide JJ, et al. Dysrhythmias after atrial surgery in children. Am Heart J 1983; 106:125-130.
3. Gelatt M, Hamilton RM, McCrindle BW, et al. Risk factors for atrial tachyarrhythmias after the Fontan operation. J Am Coll Cardiol 1994; 24:1735-1741.
4. Gewillig M, Wyse RK, de Leval MR, et al. Early and late arrhythmias after the Fontan operation: Predisposing factors and clinical consequences. Br Heart J 1992; 67:72-79.
5. Helbing WA, Hansen B, Ottenkamp J, et al. Long-term results of atrial correction for transposition of the great arteries. Comparison of Mustard and Senning operations. J Thorac Cardiovasc Surg 1994; 108:363-372.
6. Meijboom F, Szatmari A, Deckers JW, et al. Long-term follow-up (10 to 17 years) after Mustard repair for transposition of the great arteries. J Thorac Cardiovasc Surg 1996; 111:1158-1168.
7. Cetta F, Feldt RH, O'Leary PW, et al. Improved early morbidity and mortality after Fontan operation: The Mayo Clinic experience, 1987 to 1992. J Am Coll Cardiol 1996; 28:480-486.
8. Cromme-Dijkhuis AH, Hess J, Hahlen K, et al. Specific sequelae after Fontan operation at mid- and long-term follow-up: Arrhythmia, liver dysfunction, and coagulation disorders. J Thorac Cardiovasc Surg 1993; 106:1126-1132.
9. Peters NS, Somerville J. Arrhythmias after the Fontan procedure. Br Heart J 1992; 68:199-204.
10. Cecchin F, Johnsrude CL, Perry JC, et al. Effect of age and surgical technique on symptomatic arrhythmias after the Fontan procedure. Am J Cardiol 1995; 76:386-391.
11. Gardiner HM, Dhillon R, Bull C, et al. Prospective study of the incidence and determinants of arrhythmia after total cavopulmonary connection. Circulation 1996; 94[Suppl. II]:II-17-II-21.
12. Kavey RW, Gaum WE, Byrum CJ, et al. Loss of sinus rhythm after total cavopulmonary connection. Circulation 1995; 92[Suppl. II]:II-304-II-308.
13. Roos-Hesselink J, Perlroth MG, McGhie J, et al. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise and echocardiographic findings. Circulation 1995; 91:2214-2219.
14. Gelatt M, Hamilton RM, McCrindle BW, et al. Arrhythmia and mortality after the Mustard procedure: A 30-year single-center experience. J Am Coll Cardiol 1997; 29:194-210.
15. Garson A, Bink-Boelkens MThE, Hesslein PS, et al. Atrial flutter in the young: A collaborative study of 380 cases. J Am Coll Cardiol 1985; 6:871-878.
16. Balaji S, Case CL, Gillette PC. The combined use of amiodarone and class 1-C antiarrhythmic agents in children with intractable supraventricular tachyarrhythmias. Cardiol Young 1995; 5:70-74.
17. Balaji S, Johnson TB, Sade RM, et al. Management of atrial flutter after the Fontan procedure. J Am Coll Cardiol 1994; 23:1209-1215.
18. Pongiglione G, Strasburger JF, Deal BJ, et al. Use of amiodarone for short-term and adjuvant therapy in young patients. Am J Cardiol 1991; 68:603-608.
19. Campbell TJ, Gavaghan TP, Morgan JJ. Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass: comparison with disopyramide and digoxin in a randomised trial. Br Heart J 1985; 54:86-90.
20. Hohnloser SH, Woosley RL. Sotalol. N Engl J Med 1994; 331:31-37.
21. Juul-Möller S, Edvardsson N, Rehnqvist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation 1990; 82:1932-1939.
22. Reimold SC, Cantillon CO, Friedman PL, et al. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol 1993; 71:558-563.
23. Antonaccio MJ, Gomoll A. Pharmacologic basis of the antiarrhythmic and hemodynamic effects of sotalol. Am J Cardiol 1993; 72:27A-37A.
24. Hohnloser SH, Singh BN. Proarrhythmia with class III antiarrhythmic drugs: Definition, electrophysiologic mechanism, incidence, predisposing factors, and clinical implications. J Cardiovasc Electrophysiol 1995; 6:920-936.
25. Lesh MD, Kalman JM. To fumble flutter or tackle "tach"? Toward updated classifiers for atrial tachyarrhythmias. J Cardiovasc Electrophysiol 1996; 7:460-466.
26. Müller GI, Deal BJ, Strasburger JF, et al. Electrocardiographic features of atrial tachycardias after operation for congenital heart disease. Am J Cardiol 1993; 71:122-124.
27. Crijns HJGM, Van Gelder IC, Kingma JH, et al. Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug. Eur Heart J 1994; 15:1403-1408.
28. Bellandi F, Dabizzi RP, Niccoli L, et al. Propafenone and sotalol in the prevention of paroxysmal atrial fibrillation: Long-term safety and efficacy study. Curr Ther Res 1995; 56:1154-1168.
29. Camm AJ, Paul V. Sotalol for paroxysmal supraventricular tachycardias. Am J Cardiol 1990; 65:67A-73A.
30. Maragnes P, Tipple M, Fournier A. Effectiveness of oral sotalol for treatment of pediatric arrhythmias. Am J Cardiol 1992; 69:751-754.
31. Paul Th, Lehmann C, Pfammatter JP, et al. Oral sotalol in children with supraventricular and ventricular dysrhythmias. Z Kardiol 1994; 83: 891-897.
32. Tanel RE, Walsh EP, Lulu JA, et al. Sotalol for refractory arrhythmias in pediatric and young adult patients: Initial efficacy and long-term outcome. Am Heart J 1995; 130:791-797.
33. Tipple M, Sandor G. Efficacy and safety of oral sotalol in early infancy. PACE 1991; 14:2062-2065.
34. Beaufort-Krol GCM, Bink-Boelkens MThE. Effectiveness of sotalol for atrial flutter in children after surgery for congenital heart disease. Am J Cardiol 1997; 79:92-94.
35. Garson A Jr. Standard electrocardiographic diagnosis of dysrhythmias: The first step. In PC Gillette, A Garson Jr (eds.): Pediatric Cardiac Dysrhythmias. New York, Grune & Stratton, 1981, pp. 1-59.
36. Weindling SN, Saul JP, Triedman JK, et al. Recurrent intra-atrial reentry tachycardia following congenital heart disease surgery: The search for an optimum therapy, (abstract) Circulation 1995; 92:1-765.
37. MacNeil DJ, Davies RO, Deitchman D. Clinical safety profile of sotalol in the treatment of arrhythmias. Am J Cardiol 1993; 72:44A-50A.
38. Pickoff AS, Zies L, Ferrer PL, et al. High dose propranolol therapy in the management of supraventricular tachycardia. J Pediatr 1979; 94:144-146.
39. Hohnloser SH, Arendts W, Quart B. Incidence, type and dose-dependence of proarrhythmic events during sotalol therapy in patients treated for sustained VT/VF. PACE 1992; 15:173-175.